Cargando…
Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
INTRODUCTION: Identification of patients with an increased risk of high defibrillation thresholds (DFTs) is important in planning implantable cardioverter-defibrillator (ICD) procedures. Clinical observations have suggested that patients with methamphetamine cardiomyopathy (MACMP) have significantly...
Autores principales: | Malhotra, Rakesh, Patel, Shyam, Ramchand, Tekchand, Al Nimri, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784601/ https://www.ncbi.nlm.nih.gov/pubmed/29231820 http://dx.doi.org/10.1016/j.ipej.2017.07.002 |
Ejemplares similares
-
Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017) -
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018) -
Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
por: Kommuri, Naga VA, et al.
Publicado: (2010) -
Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience
por: Al-Ghamdi, Bandar, et al.
Publicado: (2017) -
Implantable cardioverter-defibrillators /
Publicado: (1994)